Skip survey header

Testing a Screening Method That May Predict Who Positively Responds to SSRIs for Treatment of PTSD

Consent to Continue

After completing this brief questionnaire, more detailed information will be given to you before you decide whether or not to take part in the research, and you will have the opportunity to speak with and ask questions of a study coordinator. You can stop this discussion at any time.
Please note that by completing this questionnaire, you consent to Trialfacts collecting your answers to the questions, including your contact information.  All information you provide in this questionnaire will be held in strict confidence, and shared only with the research center conducting the study. Trialfacts will delete your information from our records upon your request. While completing the questionnaire you will have the option to join our mailing list to be contacted via email about future clinical trials for which you may be eligible. Trialfacts may also reach out to you to gather feedback around your experience with us. You will not be contacted if you choose not to sign up to our mailing list.

For your reference, please find a link to the Trialfacts Privacy Policy.


Please note:
Due to the current situation with COVID-19 pandemic, the study team would like to point out the following:
  • The research site’s waiting area is spacious enough that participants will not be within close proximity to each other.
  • Hand sanitizers are available at the research site.
  • The research staff adheres to strict hygienic practices as well as other safety measures to prevent the spread of COVID-19. 
  • Any staff suspected to have COVID-19, or has come into contact with someone who has COVID-19, will automatically undergo a voluntary quarantine for 14 days.
  • Interested participants will not be left waiting for a long period of time and will be quickly attended to. 
  • Parking is available at the research site.
  • The research site/institution is taking all precautionary measures to ensure the safety of the study participants. 
  • The majority of the appointments will take place remotely, only 5 study appointments will be held in-person at the research site.


Are you willing to continue? *This question is required.
11%